Vaccine platform The Pirbright Institute leads vaccine development initiatives, including a three-year UK Vaccine Network-funded project for a bivalent pig vaccine and scalable RNA vaccine platform research for multiple livestock species. This presents opportunities to offer collaboration on vaccine manufacturing, safety testing, efficacy studies, and related analytical services.

Animal health focus With a strong emphasis on virus diseases of farm animals and zoonotic threats, Pirbright seeks advanced bioscience solutions to enhance containment and control. Potential sales angles include surveillance analytics, diagnostic assay development, data integration tools, and high-containment lab support platforms.

Digital infrastructure Current tech stack includes AWS, Drupal, Microsoft 365/Teams, SharePoint, New Relic, Procore, and Creative Suite, indicating openness to cloud-based collaboration, data management, monitoring, and workflow optimization services. Upsell opportunities exist in cloud cost optimization, secure data platforms, and custom dashboards.

Training and capability Recent launches of blended learning programs on engineering in biological containment and biosafety indicate a demand for modular training, certification, and digital learning delivery. Potential offerings include e-learning modules, LMS integration, regulatory-compliant training content, and virtual lab safety simulations.

Strategic collaborations Active international and multi-institution collaboration on vaccine development and pathogen research suggests appetite for partner ecosystems, contract research, and technology transfer arrangements. Business opportunities may include joint development agreements, data sharing platforms, and consultative services for regulatory strategy and product validation.